RPHM - Reneo Pharmaceuticals, Inc Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of Reneo Pharmaceuticals, Inc (RPHM)

Reneo Pharmaceuticals (RPHM) minimizes commercial risks by developing small molecules for the therapy of rare mitochondrial pathologies in collaboration with scientific centers. The current stage of capital reallocation requires strict management oversight. High scaling potential is ensured by an intellectual monopoly on the drugs. This chart of trailing 12-month sales volume versus the previous year clearly demonstrates a trend where 0.00 expresses the metric's value today.

RPHM Reneo Pharmaceuticals Inc.: Sales Growth YoY (Last Twelve Months) in the range 02/11/2024 - 02/20/2024

reneopharma.com (RPHM) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Analysis of all company metrics:Reneo Pharma
Mass-produced product of Reneo Pharmaceuticals

This metric reflects the percentage change in total commercial revenues over a rolling twelve-month period, allowing for an assessment of business scaling rates relative to the previous year. By analyzing the trailing twelve-month (TTM) sales growth, an investor can observe the transition of Reneo Pharmaceuticals (RPHM) from investment funding to the monetization of developments in the field of rare mitochondrial pathology therapies, which determines the company's future capitalization potential.

Who Reneo Pharmaceuticals competes with

VRTX (Vertex Pharmaceuticals Inc.) - Trailing Twelve Months Sales Growth|Alnylam Pharmaceuticals - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) INSM (Insmed Incorporated)|UTHR: Sales Growth YoY (TTM)|BioMarin Pharmaceutical Inc. (BMRN) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) BridgeBio Pharma Inc|Revenue Growth YoY (Last 12 Months) BGM Group Ltd (BGM)|Sales Growth YoY (Last Twelve Months) cogentbio.com (COGT)|Revenue Growth YoY (Last 12 Months) Xeris Biopharma XERS|Sales Growth YoY (TTM) KROS (kerostx.com)|Sales Growth YoY (TTM) Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Sales Growth YoY (TTM)|KMDA - Sales Growth YoY (TTM)|FULC (Fulcrum Corp) - Revenue Growth YoY (Last 12 Months)|ABEO (Abeona Therapeutics, Inc.) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Revenue Change YoY (Last 12 Months)|Sales Growth YoY (TTM) PLRX|Sales Growth YoY (Last Twelve Months) APLT (Applied Therapeutics)|Rein Therapeutics Inc - Revenue Growth YoY (Last 12 Months)|Gelteq Limited (GELS) - Trailing Twelve Months Revenue Growth|aytubio.com - Sales Growth YoY (TTM)|chemomab.com (CMMB) - Revenue Growth YoY (Last 12 Months)|SRXH: Sales Growth YoY (TTM)|Trailing Twelve Months Sales Growth PLRZ (Polyrizon Ltd.)|Revenue Growth YoY (Last 12 Months) AEZS|CYTH: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) inozyme.com (INZY)|CSCI (COSCIENS Biopharma) - Revenue Dynamics YoY (Last Twelve Months)